Robert Rosecrans1, James C Dohnal2. 1. NorthShore University HealthSystem, Evanston Hospital, Department of Pathology and Laboratory Medicine, 2650 Ridge Avenue, Evanston, IL 60201, USA. Electronic address: rrosecrans@northshore.org. 2. NorthShore University HealthSystem, Evanston Hospital, Department of Pathology and Laboratory Medicine, 2650 Ridge Avenue, Evanston, IL 60201, USA. Electronic address: jdohnal@northshore.org.
Abstract
OBJECTIVE: To investigate seasonal variation of vitamin D levels in 148,821 serum samples during a 2year time period in a northern-latitude city in the United States. METHODS: Total vitamin D assay testing by chemiluminescence was performed on the DiaSorin Liaison. Vitamin D results were extracted from the laboratory information system without patient identification during 2011 and 2012 and separated by season and vitamin D results: less than 10ng/mL (deficient), 10-20.0ng/mL (insufficient), 20.1-30ng/mL (borderline), 30.1-40ng/mL (sufficient), 40.1-100ng/mL, and greater than 100ng/mL. RESULTS: The seasonal winter period constituted the months of January through March; spring, April through June; summer, July through September; and fall, October through December. The data set analyzed included 36,643 samples during the winter, 38,299 in spring, 36,141 in summer, and 37,738 in fall and demonstrated an expected rise and fall in vitamin D levels. CONCLUSION: This retrospective epidemiological study demonstrates seasonal variation of vitamin D levels at clinical decision points. Although not unexpected, this variation has an impact on studies relating low vitamin D levels to higher rates of cancer, cardiovascular disease, multiple sclerosis, diabetes, autoimmune disease, and a host of other health risk assessments.
OBJECTIVE: To investigate seasonal variation of vitamin D levels in 148,821 serum samples during a 2year time period in a northern-latitude city in the United States. METHODS: Total vitamin D assay testing by chemiluminescence was performed on the DiaSorin Liaison. Vitamin D results were extracted from the laboratory information system without patient identification during 2011 and 2012 and separated by season and vitamin D results: less than 10ng/mL (deficient), 10-20.0ng/mL (insufficient), 20.1-30ng/mL (borderline), 30.1-40ng/mL (sufficient), 40.1-100ng/mL, and greater than 100ng/mL. RESULTS: The seasonal winter period constituted the months of January through March; spring, April through June; summer, July through September; and fall, October through December. The data set analyzed included 36,643 samples during the winter, 38,299 in spring, 36,141 in summer, and 37,738 in fall and demonstrated an expected rise and fall in vitamin D levels. CONCLUSION: This retrospective epidemiological study demonstrates seasonal variation of vitamin D levels at clinical decision points. Although not unexpected, this variation has an impact on studies relating low vitamin D levels to higher rates of cancer, cardiovascular disease, multiple sclerosis, diabetes, autoimmune disease, and a host of other health risk assessments.
Authors: Marie D Jena; Peter W Marcello; Patricia L Roberts; Thomas E Read; David J Schoetz; Jason F Hall; Todd Francone; Rocco Ricciardi Journal: Clin Colon Rectal Surg Date: 2016-09
Authors: S D'Andrea; A Martorella; F Coccia; C Castellini; E Minaldi; M Totaro; A Parisi; F Francavilla; S Francavilla; A Barbonetti Journal: Endocrine Date: 2020-09-03 Impact factor: 3.633
Authors: Mauricio F Farez; Ivan D Mascanfroni; Santiago P Méndez-Huergo; Ada Yeste; Gopal Murugaiyan; Lucien P Garo; María E Balbuena Aguirre; Bonny Patel; María C Ysrraelit; Chen Zhu; Vijay K Kuchroo; Gabriel A Rabinovich; Francisco J Quintana; Jorge Correale Journal: Cell Date: 2015-09-10 Impact factor: 41.582
Authors: Christoph Amadeus Agten; Lukas Margaroli; Susanne Bensler; Benjamin Fritz; Andrea B Rosskopf; Ulrike Held; Christian W A Pfirrmann Journal: Skeletal Radiol Date: 2018-02-02 Impact factor: 2.199
Authors: Chadi A Calarge; James A Mills; Ekhard E Ziegler; Janet A Schlechte Journal: J Child Adolesc Psychopharmacol Date: 2017-11-07 Impact factor: 2.576